Aeromonas spontaneous bacterial peritonitis: A highly fatal infectious disease in patients with advanced liver cirrhosis

Journal of the Formosan Medical Association

Volumn 108, Issue 4, 2009, Pages 293-300

  Wu, Chi Jung ^a,b   Lee, Hsin Chun ^a,b   Chang, Ting Tsung ^a,b   Chen, Chiung Yu ^a,b   Lee, Nan Yao ^b   Chang, Chia Ming ^b   Sheu, Bor Shyang ^a,b   Cheng, Pin Nan ^b   Shih, Hsin I ^b   Ko, Wen Chien ^a,b  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^b NATIONAL CHENG KUNG UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Aeromonas; Gram negative bacteria; Liver cirrhosis; Peritonitis; Taiwan

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; CEFALOTIN; CEFAZOLIN; CEFOTAXIME; CEFTRIAXONE; CEFUROXIME; CEPHALOSPORIN DERIVATIVE; GENTAMICIN; LEVOFLOXACIN; LOMEFLOXACIN; NORFLOXACIN; OFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ABDOMINAL PAIN; ACUTE KIDNEY FAILURE; ADULT; AEROMONAS; AEROMONAS HYDROPHILA; AEROMONAS SOBRIA; AGED; ANTIBIOTIC SENSITIVITY; ARTICLE; ASCITES FLUID; BACTEREMIA; BACTERIAL PERITONITIS; BACTERIUM ISOLATION; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; FEVER; GRAM NEGATIVE BACTERIUM; HOSPITAL ADMISSION; HUMAN; HYPOTENSION; LIVER CIRRHOSIS; MALE; MEDICAL RECORD; MENTAL DISEASE; MORTALITY; NONHUMAN; PARACENTESIS; PROGNOSIS; SCORING SYSTEM; TAIWAN;

EID: 65549154339     PISSN: 09296646     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0929-6646(09)60069-3     Document Type: Article

References (38)

1. Isonhood JH, Drake M. Aeromonas species in foods. J Food Prot 2002;65:575-82.
2. Janda JM, Abbott SL. Evolving concepts regarding the genus Aeromonas: an expanding panorama of species, disease presentations, and unanswered questions. Clin Infect Dis 1998; 27:332-44.
3. Ong KR, Sordillo E, Frankel E. Unusual case of Aeromonas hydrophila endocarditis. J Clin Microbiol 1991;29:1056-7.
4. Munoz P, Fernandez-Baca V, Pelaez T, et al. Aeromonas peritonitis. Clin Infect Dis 1994;18:32-7.
5. Chan FK, Ching JY, Ling TK, et al. Aeromonas infection in acute suppurative cholangitis: review of 30 cases. J Infect 2000;40:69-73.
6. Franca A, Giordano HM, Seva-Pereira T, et al. Five days of ceftriaxone to treat spontaneous bacterial peritonitis in cirrhotic patients. J Gastroenterol 2002;37:119-22.
7. Saez-Royuela F, Gomez Rubio M, Fernandez Guerrero ML, et al. A microbiological and clinical study of 57 cases of spontaneous bacterial peritonitis in liver cirrhosis patients. Rev Clin Esp 1990;187:321-4.
8. Gomez-Jimenez J, Ribera E, Martinez-Vazquez JM, et al. Bacterial peritonitis in cirrhosis. Prospective study of 80 episodes. Med Clin (Barc) 1992;99:493-7.
9. Franca AV, De Souza JB, Silva CM, et al. Long-term prognosis of cirrhosis after spontaneous bacterial peritonitis treated with ceftriaxone. J Clin Gastroenterol 2001;33: 295-8.
10. Park YH, Lee HC, Song HG, et al. Recent increase in antibiotic-resistant microorganisms in patients with spontaneous bacterial peritonitis adversely affects the clinical outcome in Korea. J Gastroenterol Hepatol 2003;18: 927-33.
11. Chu CM, Chiu KW, Liaw YF. The prevalence and prognostic significance of spontaneous bacterial peritonitis in severe acute hepatitis with ascites. Hepatology 1992;15:799-803.
12. Ko WC, Chuang YC. Aeromonas bacteremia: review of 59 episodes. Clin Infect Dis 1995;20:1298-304.
13. Ko WC, Lee HC, Chuang YC, et al. Clinical features and therapeutic implications of 104 episodes of monomicrobial Aeromonas bacteraemia. J Infect 2000;40:267-73.
14. Kuo CH, Changchien CS, Yang CY, et al. Bacteremia in patients with cirrhosis of the liver. Liver 1991;11:334-9.
15. Huang LJ, Chen HP, Chen TL, et al. Secondary Aeromonas peritonitis is associated with polymicrobial ascites culture and absence of liver cirrhosis compared to primary Aeromonas peritonitis. APMIS 2006;114:772-8.
16. Garcia M, Sanroman AL, Gisbert JP, et al. Aeromonas sobria spontaneous bacterial peritonitis. Am J Gastroenterol 1992;87:1890-1.
17. Ruiz de Gonzalez P, Escolano C, Rodriguez JC, et al. Aeromonas sobria spontaneous bacterial peritonitis and bacteremia. Am J Gastroenterol 1994;89:290-1.
18. Cordoba Lopez A, Bueno Alvarez-Arenas MI, Alzugaray Fraga RJ, et al. Spontaneous bacterial peritonitis and sepsis due to Aeromonas hydrophila. Gastroenterol Hepatol 1999;22:208.
19. Melhus A. First documented case of Aeromonas veronii biovar sobria infection in northern Europe. Scand J Infect Dis 2002;34:218-9.
20. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Disk Susceptibility Tests. Approved Standard M2-A8, 8th edition, 2005.
21. Rimola A, Garcia-Tsao G, Navasa M, et al. Diagnosis, treatment and prophylaxis of spontaneous bacterial peritonitis: a consensus document. International Ascites Club. J Hepatol 2000;32:142-53.
22. Pugh RN, Murray-Lyon IM, Dawson JL, et al. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 1973;60:646-9.
23. Chow JW, Yu VL. Combination antibiotic therapy versus monotherapy for Gram-negative bacteraemia: a commentary. Int J Antimicrob Agents 1999;11:7-12.
24. Yaun SS, Lin LP. Isolation and characterization of Aeromonas from seafoods in Taipei. Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi 1993;26:78-85.
25. Chen CJ, Wang LY, Yu MW. Epidemiology of hepatitis B virus infection in the Asia-Pacific region. J Gastroenterol Hepatol 2000;15(Suppl):E3-6.
26. Lin CC, Hwang SJ, Chiou ST, et al. The prevalence and risk factors analysis of serum antibody to hepatitis C virus in the elders in northeast Taiwan. J Chin Med Assoc 2003;66: 103-8.
27. Janda JM, Kokka RP. The pathogenicity of Aeromonas strains relative to genospecies and phenospecies identification. FEMS Microbiol Lett 1991;69:29-33.
28. Wilcox MH, Cook A, Geary I, et al. Toxin production, adherence and protein expression by clinical Aeromonas spp. isolates in broth and human pooled ileostomy fluid. Epidemiol Infect 1994; 113:235-45.
29. Thanopoulou AC, Koskinas JS, Hadziyannis SJ. Spontaneous bacterial peritonitis (SBP): clinical, laboratory, and prognostic features. A single-center experience. Eur J Intern Med 2002;13:194-8.
30. Kachintorn U, Chainuvati T, Chinapak O, et al. Spontaneous bacterial peritonitis in cirrhotics: clinical and ascitic fluid findings. Ann Acad Med Singapore 1986;15:221-6.
31. Filik L, Unal S. Clinical and laboratory features of spontaneous bacterial peritonitis. East Afr Med J 2004;81:474-9.
32. Caly WR, Strauss E. A prospective study of bacterial infections in patients with cirrhosis. J Hepatol 1993;18:353-8.
33. Soriano G, Coll P, Guarner C, et al. Escherichia coli capsular polysaccharide and spontaneous bacterial peritonitis in cirrhosis. Hepatology 1995;21:668-73.
34. Ko WC, Chiang SR, Yan JJ, et al. Comparative pathogenicity of bacteraemic isolates of Aeromonas hydrophila and Klebsiella pneumoniae. Clin Microbiol Infect 2005;11:553-8.
35. Felisart J, Rimola A, Arroyo V, et al. Cefotaxime is more effective than is ampicillin-tobramycin in cirrhotics with severe infections. Hepatology 1985;5:457-62.
36. Ko WC, Wu HM, Chang TC, et al. Inducible beta-lactam resistance in Aeromonas hydrophila: therapeutic challenge for antimicrobial therapy. J Clin Microbiol 1998;36:3188-92.
37. Ko WC, Lee HC, Chuang YC, et al. In vitro and in vivo combinations of cefotaxime and minocycline against Aeromonas hydrophila. Antimicrob Agents Chemother 2001;45:1281-3.
38. Ko WC, Chiang SR, Lee HC, et al. In vitro and in vivo activities of fluoroquinolones against Aeromonas hydrophila. Antimicrob Agents Chemother 2003;47: 2217-22.